- Topic
89k Popularity
42k Popularity
14k Popularity
12k Popularity
5k Popularity
4k Popularity
16k Popularity
22k Popularity
13k Popularity
3k Popularity
- Pin
- 🌟 Photo Sharing Tips: How to Stand Out and Win?
1.Highlight Gate Elements: Include Gate logo, app screens, merchandise or event collab products.
2.Keep it Clear: Use bright, focused photos with simple backgrounds. Show Gate moments in daily life, travel, sports, etc.
3.Add Creative Flair: Creative shots, vlogs, hand-drawn art, or DIY works will stand out! Try a special [You and Gate] pose.
4.Share Your Story: Sincere captions about your memories, growth, or wishes with Gate add an extra touch and impress the judges.
5.Share on Multiple Platforms: Posting on Twitter (X) boosts your exposure an
- 🎉 [Gate 30 Million Milestone] Share Your Gate Moment & Win Exclusive Gifts!
Gate has surpassed 30M users worldwide — not just a number, but a journey we've built together.
Remember the thrill of opening your first account, or the Gate merch that’s been part of your daily life?
📸 Join the #MyGateMoment# campaign!
Share your story on Gate Square, and embrace the next 30 million together!
✅ How to Participate:
1️⃣ Post a photo or video with Gate elements
2️⃣ Add #MyGateMoment# and share your story, wishes, or thoughts
3️⃣ Share your post on Twitter (X) — top 10 views will get extra rewards!
👉
The identification of the executive director of Linghang Medical Biotechnology is exposed: Two founders of Conflux hold concurrent positions.
According to Gate News bot, the latest public information shows that Long Fan and Wu Ming, the two founders of Conflux, also serve as executive directors of the Hong Kong-listed company Leading Pharmaceutical Biotechnology.
Navi Pharmaceutical Biotechnology currently has a total market value of approximately HKD 371 million (equivalent to USD 47.26 million). Meanwhile, the total market value of Conflux (CFX) token has reached USD 393 million, ranking 138th in the cryptocurrency market capitalization leaderboard.
Earlier reports indicated that Pioneer Pharma Biotechnology (00399) announced that the company will sign a memorandum of understanding with Northwestern Foundation (the seller) and Conflux on June 30, 2025, with the intention of acquiring all the shares of the target company. This potential acquisition aims to assist the company in entering the digital innovation field, which will not only diversify the group’s business but is also expected to bring new profit growth points for the group.